Unveiling immunity gaps and determining a suitable age for a third dose of the measles-containing vaccine: a strategic approach to accelerating measles elimination.

Lancet Reg Health Southeast Asia · 2025 · PMC11732191 · PMID 39811540

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Posterior predictive curves for the age-stratified seroprevalence exhibited a decreasing trend from ages 13–20 years but an upward trend from 26 to 30 years.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.